Aurinia Pharmaceuticals Stock Price on March 8, 2024
| AUPH Stock | USD 4.91 0.04 0.82% |
Below is the normalized historical share price chart for Aurinia Pharmaceuticals extending back to July 16, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aurinia Pharmaceuticals stands at 4.91, as last reported on the 28th of April, with the highest price reaching 5.01 and the lowest price hitting 4.86 during the day.
If you're considering investing in Aurinia Stock, it is important to understand the factors that can impact its price. Aurinia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17% return per unit of risk over the last 3 months. Aurinia Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurinia Pharmaceuticals' Standard Deviation of 3.91, mean deviation of 2.28, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide.
As of now, Aurinia Pharmaceuticals' Common Stock Total Equity is increasing as compared to previous years. The Aurinia Pharmaceuticals' current Common Stock is estimated to increase to about 1.3 B, while Other Stockholder Equity is projected to decrease to under 66.4 M. . As of now, Aurinia Pharmaceuticals' Price Fair Value is increasing as compared to previous years. Aurinia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of January 1999 | 200 Day MA 7.8797 | 50 Day MA 5.2886 | Beta 1.379 |
Aurinia |
Sharpe Ratio = -0.1721
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AUPH |
Estimated Market Risk
| 3.95 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aurinia Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurinia Pharmaceuticals by adding Aurinia Pharmaceuticals to a well-diversified portfolio.
Price Book 1.9514 | Enterprise Value Ebitda (7.69) | Price Sales 4.2023 | Shares Float 131.7 M | Wall Street Target Price 11.29 |
Related Headline
ImmunoGen Headline on 9th of February 2024
ImmunoGen witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesnt suggest further strength down the road.
Aurinia Pharmaceuticals Valuation on March 8, 2024
It is possible to determine the worth of Aurinia Pharmaceuticals on a given historical date. On March 8, 2024 Aurinia was worth 5.46 at the beginning of the trading date compared to the closed value of 5.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aurinia Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Aurinia Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aurinia Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aurinia Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 5.51 | 5.58 | 5.39 | 5.45 | 1,342,221 | |
03/08/2024 | 5.46 | 5.63 | 5.40 | 5.43 | 1,353,113 |
| 5.40 | 5.56 | 5.35 | 5.37 | 1,469,156 |
| Backtest Aurinia Pharmaceuticals | | | Aurinia Pharmaceuticals History | | | Aurinia Pharmaceuticals Valuation | Previous | Next |
Aurinia Pharmaceuticals Trading Date Momentum on March 8, 2024
| On March 11 2024 Aurinia Pharmaceuticals was traded for 5.37 at the closing time. The top price for the day was 5.56 and the lowest listed price was 5.35 . The trading volume for the day was 1.5 M. The trading history from March 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.10% . The overall trading delta against the current closing price is 4.60% . |
Aurinia Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Aurinia Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aurinia Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aurinia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aurinia Pharmaceuticals Stock history
Aurinia Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aurinia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aurinia Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aurinia Pharmaceuticals stock prices may prove useful in developing a viable investing in Aurinia Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 143.2 M | 150.4 M | |
| Net Loss | -97.4 M | -92.5 M |
Aurinia Pharmaceuticals Quarterly Net Working Capital |
|
Aurinia Pharmaceuticals Stock Technical Analysis
Aurinia Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aurinia Pharmaceuticals Period Price Range
Low | March 8, 2024
| High |
5.46 | 5.43 |
Aurinia Pharmaceuticals April 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Aurinia Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aurinia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aurinia Pharmaceuticals stock market strength indicators, traders can identify Aurinia Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 55278.15 | |||
| Daily Balance Of Power | (0.13) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 5.52 | |||
| Day Typical Price | 5.49 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.52) |
Aurinia Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aurinia Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aurinia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aurinia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (0.96) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Aurinia Stock analysis
When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Aurinia Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.225 | Quarterly Revenue Growth 0.586 | Return On Assets (0.11) | Return On Equity (0.20) |
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.